NEW YORK, May 12 Reportlinker.com announces that a new market research report is available in its catalogue:
China Diabetes Care Devices Market Outlook to 2016
Advertisement
http://www.reportlinker.com/p0196610/China-Diabetes-Care-Devices-Market-Outlook-to-2016.html
China Diabetes Care Devices Market Outlook to 2016
Advertisement
Summary
GlobalData's medical equipment report offering, "China Diabetes Care Devices Market Outlook to 2016" provides key market data on the China diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for two diabetes care devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the China diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China diabetes care devices competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Diabetes Care Devices In China 11
3.1 Diabetes Care Devices, Market Segmentation 11
3.2 Diabetes Care Devices, China, Overall Revenue ($m), 2002-2016 12
3.3 Diabetes Care Devices Market, China, Revenue Mix ($m), 2009 13
3.4 Diabetes Care Devices Market, China, Category Contribution (%), 2009 14
3.5 Diabetes Care Devices, China, Category Volume (Units), 2002-2016 18
3.6 Diabetes Care Devices, China, Company Share (2008-2009) 21
4 Glucose Monitoring In China 23
4.1 Glucose Monitoring, Market Segmentation 23
4.2 Glucose Monitoring Market, China, Revenue Mix ($m), 2009 24
4.3 Glucose Monitoring Market, China, Category Contribution (%), 2009 25
4.4 Glucose Monitoring Overall Revenue (2002-2016) 26
4.4.1 Blood Glucose Meters Revenue (2002-2016) 28
4.5 Glucose Monitoring Overall Volume (2002-2016) 30
4.5.1 Blood Glucose Meters Volume (2002-2016) 32
4.6 Glucose Monitoring Average Price (2002-2016) 34
4.7 Glucose Monitoring Distribution Share (2008-2009) 35
4.8 Glucose Monitoring, China, Company Share (2008-2009) 36
5 Insulin Delivery In China 38
5.1 Insulin Delivery, Market Segmentation 38
5.2 Insulin Delivery Market, China, Revenue Mix ($m), 2009 39
5.3 Insulin Delivery Market, China, Category Contribution (%), 2009 40
5.4 Insulin Delivery Overall Revenue (2002-2016) 41
5.4.1 Insulin Pens Revenue (2002-2016) 43
5.5 Insulin Delivery Overall Volume (2002-2016) 45
5.5.1 Insulin Pens Volume (2002-2016) 47
5.6 Insulin Delivery Average Price (2002-2016) 49
5.7 Insulin Delivery Distribution Share (2008-2009) 50
5.8 Insulin Delivery, China, Company Share (2008-2009) 51
6 Overview of Key Companies in China Diabetes Care Devices Market 53
6.1 F. Hoffmann-La Roche Ltd. 53
6.1.1 Company Overview 53
6.1.2 Share in the China Diabetes Care Devices Market 53
6.2 Novo Nordisk A/S 54
6.2.1 Company Overview 54
6.2.2 Share in the China Diabetes Care Devices Market 546.3 LifeScan, Inc. 55
6.3.1 Company Overview 55
6.3.2 Share in the China Diabetes Care Devices Market 55
6.4 Eli Lilly and Company 56
6.4.1 Company Overview 56
6.4.2 Share in the China Diabetes Care Devices Market 56
6.5 Medtronic, Inc. 57
6.5.1 Company Overview 57
6.5.2 Share in the China Diabetes Care Devices Market 57
6.6 Sanofi-Aventis 58
6.6.1 Company Overview 58
6.6.2 Share in the China Diabetes Care Devices Market 58
6.7 Abbott Laboratories 59
6.7.1 Company Overview 59
6.7.2 Share in the China Diabetes Care Devices Market 59
6.8 Becton, Dickinson and Company 60
6.8.1 Company Overview 60
6.8.2 Share in the China Diabetes Care Devices Market 60
6.9 Terumo Corporation 61
6.9.1 Company Overview 61
6.10 Smiths Medical 61
6.10.1 Company Overview 61
6.11 BIONIME Corporation 62
6.11.1 Company Overview 62
6.12 Bayer HealthCare AG 62
6.12.1 Company Overview 62
6.13 AViTA Corporation 63
6.13.1 Company Overview 63
6.14 ARKRAY, Inc. 63
6.14.1 Company Overview 63
6.15 Apex Biotechnology Corp. 63
6.15.1 Company Overview 63
6.16 Animas Corporation 64
6.16.1 Company Overview 64
7 Diabetes Care Devices Market Pipeline Products 65
8 Financial Deals Landscape 68
8.1 Partnerships 68
8.1.1 Insulet Enters Into Distribution Agreement with Ypsomed Holding 68
9 Recent Developments 69
9.1 Strategy and Business Planning 69
9.1.1 Nov 18, 2009: Elos Pinol Expands Agreement with Novo Nordisk for Insulin Pens 6910 Appendix 70
10.1 Definitions of Markets Covered in the Report 71
10.1.1 Diabetes Care Devices 71
10.2 Research Methodology 73
10.3 Secondary Research 74
10.4 Primary Research 74
10.5 Models 75
10.6 Forecasts 75
10.7 Expert Panels 75
10.8 Currency Conversion 76
10.9 Contact Us 76
10.10 Disclaimer 76
List of Tables
1.1 List of Tables
Table 1: Diabetes Care Devices, China, Overall Revenue ($m), 2002-2016 12
Table 2: Diabetes Care Devices Market, China, Category Contribution (%), 2009 14
Table 3: Diabetes Care Devices, China, Cross-Segment Analysis, 2002-2016 15
Table 4: Diabetes Care Devices, China, Overall Revenue ($m), Historic, 2002-2009 16
Table 5: Diabetes Care Devices, China, Overall Revenue ($m), Forecast, 2009-2016 17
Table 6: Diabetes Care Devices, China, Category Volume (Units), 2002-2016 18
Table 7: Diabetes Care Devices, China, Category Volume (Units), Historic, 2002-2009 19
Table 8: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2009-2016 20
Table 9: Diabetes Care Devices, China, Company Share by Revenue ($m), 2008-2009 22
Table 10: Glucose Monitoring Market, China, Category Contribution (%), 2009 25
Table 11: Glucose Monitoring, China, Revenue ($m) by Segment, Historic, 2002-2009 26
Table 12: Glucose Monitoring, China, Revenue ($m) by Segment, Forecast, 2009-2016 27
Table 13: Blood Glucose Meters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 28
Table 14: Blood Glucose Meters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 29
Table 15: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2002-2009 30
Table 16: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2009-2016 31
Table 17: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2002-2009 32
Table 18: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2009-2016 33
Table 19: Glucose Monitoring, China, Average Price ($), Historic, 2002-2009 34
Table 20: Glucose Monitoring, China, Average Price ($), Forecast, 2009-2016 34
Table 21: Glucose Monitoring, China, Distribution Share by Revenue ($m), 2008-2009 35
Table 22: Glucose Monitoring, China, Company Share by Revenue ($m), 2008-2009 37
Table 23: Insulin Delivery Market, China, Category Contribution (%), 2009 40
Table 24: Insulin Delivery, China, Revenue ($m) by Segment, Historic, 2002-2009 41
Table 25: Insulin Delivery, China, Revenue ($m) by Segment, Forecast, 2009-2016 42
Table 26: Insulin Pens, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Table 27: Insulin Pens, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Table 28: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2002-2009 45
Table 29: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2009-2016 46
Table 30: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Table 31: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Table 32: Insulin Delivery, China, Average Price ($), Historic, 2002-2009 49
Table 33: Insulin Delivery, China, Average Price ($), Forecast, 2009-2016 49
Table 34: Insulin Delivery, China, Distribution Share by Revenue ($m), 2008-2009 50
Table 35: Insulin Delivery, China, Company Share by Revenue ($m), 2008-2009 52
Table 36: Diabetes Care Devices Pipeline Products 65Table 37: Insulet Enters Into Distribution Agreement With Ypsomed Holding 68
Table 38: USD to Local Currency, China, Average Actual Rate 2002-2009 76
List of Figures
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 11
Figure 2: Diabetes Care Devices, China, Overall Revenue ($m), 2002-2016 12
Figure 3: Diabetes Care Devices Market, China, Revenue Mix ($m), 2009 13
Figure 4: Diabetes Care Devices Market, China, Category Contribution (%), 2009 14
Figure 5: Diabetes Care Devices, China, Cross-Segment Analysis, 2002-2016 15
Figure 6: Diabetes Care Devices, China, Overall Revenue ($m), Historic, 2002-2009 16
Figure 7: Diabetes Care Devices, China, Overall Revenue ($m), Forecast, 2009-2016 17
Figure 8: Diabetes Care Devices, China, Category Volume (Units), 2002-2016 18
Figure 9: Diabetes Care Devices, China, Category Volume (Units), Historic, 2002-2009 19
Figure 10: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2009-2016 20
Figure 11: Diabetes Care Devices, China, Company Share (%), 2009 21
Figure 12: Glucose Monitoring, Market Segmentation 23Figure 13: Glucose Monitoring Market, China, Revenue Mix ($m), 2009 24
Figure 14: Glucose Monitoring Market, China, Category Contribution (%), 2009 25
Figure 15: Glucose Monitoring, China, Revenue ($m) by Segment, Historic, 2002-2009 26
Figure 16: Glucose Monitoring, China, Revenue ($m) by Segment, Forecast, 2009-2016 27
Figure 17: Blood Glucose Meters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 28
Figure 18: Blood Glucose Meters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 29
Figure 19: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2002-2009 30
Figure 20: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2009-2016 31
Figure 21: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2002-2009 32
Figure 22: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2009-2016 33
Figure 23: Glucose Monitoring, China, Company Share (%), 2009 36
Figure 24: Insulin Delivery, Market Segmentation 38
Figure 25: Insulin Delivery Market, China, Revenue Mix ($m), 2009 39
Figure 26: Insulin Delivery Market, China, Category Contribution (%), 2009 40
Figure 27: Insulin Delivery, China, Revenue ($m) by Segment, Historic, 2002-2009 41
Figure 28: Insulin Delivery, China, Revenue ($m) by Segment, Forecast, 2009-2016 42
Figure 29: Insulin Pens, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Figure 30: Insulin Pens, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Figure 31: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2002-2009 45
Figure 32: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2009-2016 46
Figure 33: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Figure 34: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Figure 35: Insulin Delivery, China, Company Share (%), 2009 51
Figure 36: F. Hoffmann-La Roche Ltd, Company Share (%), China Diabetes Care Devices Market, 2009 53
Figure 37: Novo Nordisk A/S, Company Share (%), China Diabetes Care Devices Market, 2009 54
Figure 38: LifeScan, Inc., Company Share (%), China Diabetes Care Devices Market, 2009 55
Figure 39: Eli Lilly and Company, Company Share (%), China Diabetes Care Devices Market, 2009 56
Figure 40: Medtronic, Inc., Company Share (%), China Diabetes Care Devices Market, 2009 57
Figure 41: Sanofi-Aventis, Company Share (%), China Diabetes Care Devices Market, 2009 58
Figure 42: Abbott Laboratories, Company Share (%), China Diabetes Care Devices Market, 2009 59
Figure 43: Becton, Dickinson and Company, Company Share (%), China Diabetes Care Devices Market, 2009 60
Figure 44: GlobalData Methodology 73
Companies Mentioned
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
LifeScan, Inc.
Eli Lilly and Company
Medtronic, Inc.
Sanofi-Aventis
Abbott Laboratories
Becton, Dickinson and Company
Terumo Corporation
Smiths Medical
BIONIME Corporation
Bayer HealthCare AG
AViTA Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation
To order this report:
Medical Devices Industry: China Diabetes Care Devices Market Outlook to 2016
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
